default author photo

Martha Montgomery

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

40

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 µg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA

Number of pages: 22 Posted: 26 Feb 2026
Kriengkrai Prasert, Sutthichai Nakphook, Jiraphut Kittiwatanachod, Darunee Ditsungneon, Kanlaya Sornwong, Suriya Naosri, Ponthip Wirachwong, Isariya Techatanawat, Piengthong Narakorn, Surichan S, Jorge Flores, Laina Mercer, Christina Polyak, Bruce L. Innis, Rama Raghunandan, Chakrarat Pittayawonganon, Sopon Iamsirithaworn, Supakit Sirilak, Colleen Scott, Martha Montgomery, William W. Davis and Prabda Praphasiri
Ministry of Public Health, Thailand, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, PATH, Institute for Disease Modeling, PATH, PATH, PATH, Ministry of Public Health, Thailand, affiliation not provided to SSRN, Bureau of Policy and Strategy, Nonthaburi, Thailand, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United States of America - Influenza Division and affiliation not provided to SSRN
Downloads 40 (1,222,651)

Abstract:

Loading...

COVID-19 vaccine, Phase III clinical trial, inactivated recombinant NDV-HXP-S vaccine, secondary immunization, Thailand.